http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013125636-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc0528072c4ddfb3545aae484fe76b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bff695bcb240f2403f6645eb83e98861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e4f800f86737e395cdf5599cafbaff1
publicationDate 2013-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013125636-A1
titleOfInvention Pharmaceutical composition for treatment and/or prevention of cancer
abstract The present invention discloses an antibody that targets a cancer antigen protein expressed specifically on the surface of cancer cells, and the application of the antibody in a treatment and/or preventative agent for said cancer. Specifically disclosed are: an antibody or a fragment thereof, said antibody being immunologically reactive with a partial polypeptide of CAPRIN-1 comprising the amino acid sequence represented by SEQ ID NO: 5 or an amino acid sequence having 80% or more sequence identity to the amino acid sequence represented by SEQ ID NO: 5; and a pharmaceutical composition for the treatment and/or prevention of cancer, said pharmaceutical composition being characterized by containing, as an active ingredient, the antibody or a fragment thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021081407-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9758591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160038892-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020252294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021067242-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11312787-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021226440-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654193-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018079740-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023076599-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015020212-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021182570-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021182572-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021182571-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10344096-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021182574-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021182573-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019189780-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022036101-A1
priorityDate 2012-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011096534-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02092812-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011096535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9951743-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011096517-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9846777-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011096519-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011096528-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012035484-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010016526-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5698396-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007530068-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010016527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0243478-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0239400-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011096533-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110

Total number of triples: 69.